Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change $ Change
grade B $65.62 -0.05% -0.03
ABBV closed down 0.05 percent on Friday, March 24, 2017, on 59 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical ABBV trend table...

Date Alert Name Type % Chg
Mar 24 Three Weeks Tight Range Contraction 0.00%
Mar 24 Cup with Handle Other 0.00%
Mar 23 Cup with Handle Other -0.05%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.15%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.15%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup 0.41%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.41%
Mar 20 1,2,3 Pullback Bullish Bullish Swing Setup -0.27%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.27%
Mar 17 Cup with Handle Other -0.11%

Older signals for ABBV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 67.5
52 Week Low 54.82
Average Volume 6,851,493
200-Day Moving Average 62.311
50-Day Moving Average 62.5356
20-Day Moving Average 64.642
10-Day Moving Average 65.76
Average True Range 0.8577
ADX 42.77
+DI 24.92
-DI: 8.14
Chandelier Exit (Long, 3 ATRs) 64.2169
Chandelier Exit (Short, 3 ATRs) 64.0231
Upper Bollinger Band 67.3974
Lower Bollinger Band 61.8866
Percent B (%b) 0.68
Bandwidth 0.085251